Back
  1. Home
  2. Profile of Louise Vrancken (ULiège)
Profil

Vrancken Louise

GIGA I3 - Hematology

Département des sciences cliniques > GIGA

Hématologie

See author's contact details
Main Referenced Co-authors
Baron, Frédéric  (6)
Beguin, Yves  (6)
Delens, Loïc  (6)
Dubois, Sophie  (6)
Ehx, Grégory  (6)
Main Referenced Keywords
Th17 (6); NSG mice (4); GVHD (2); Humans (2); Immunotherapy (2);
Main Referenced Unit & Research Centers
Giga-Infection, Immunity and Inflammation Laboratoire d'hématologie (4)
Main Referenced Disciplines
Hematology (5)
Immunology & infectious disease (3)
Biochemistry, biophysics & molecular biology (3)
Laboratory medicine & medical technology (1)
Radiology, nuclear medicine & imaging (1)

Publications (total 11)

The most downloaded
531 downloads
Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488. https://hdl.handle.net/2268/260541

The most cited

119 citations (Scopus®)

Faict, S., Muller, J., De Veirman, K., De Bruyne, E., Maes, K., Vrancken, L., Heusschen, R., De Raeve, H., Schots, R., Vanderkerken, K., Caers, J., & Menu, E. (2018). Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer Journal, 8 (11), 105. doi:10.1038/s41408-018-0139-7 https://hdl.handle.net/2268/233062

Articles accepted in reviewed journal

Kegyes, D.* , Constantinescu, C.* , Vrancken, L., Rasche, L., Grégoire, C., Tigu, B., Gulei, D., Dima, D., Tanase, A., Einsele, H., Ciurea, S., Tomuleasa, C., & Caers, J. (07 June 2022). Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient? Journal of Hematology and Oncology, 15 (1), 78. doi:10.1186/s13045-022-01296-2
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Caers, J., Duray, E., Vrancken, L., Marcion, G., Bocuzzi, V., De Veirman, K., Krasniqi, A., Lejeune, M., Withofs, N., Devoogdt, N., Dumoulin, M., Karlström, A. E., & D'Huyvetter, M. (2022). Radiotheranostic Agents in Hematological Malignancies. Frontiers in Immunology, 13, 911080. doi:10.3389/fimmu.2022.911080
Peer Reviewed verified by ORBi

Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488.
Peer reviewed

Delens, L., Ehx, G., SOMJA, J., Vrancken, L., Belle, L., SEIDEL, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & Servais, S. (2019). In Vitro Th17-Polarized Human CD4(+) T Cells Exacerbate Xenogeneic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation, 25, 204-215. doi:10.1016/j.bbmt.2018.10.007
Peer Reviewed verified by ORBi

Vercruyssen, M., Vrancken, L., & CAERS, J. (2018). What is new in MGUS and smoldering multiple myeloma. Belgian Journal of Hematology, 9, 2-7.
Peer Reviewed verified by ORBi

Faict, S., Muller, J., De Veirman, K., De Bruyne, E., Maes, K., Vrancken, L., Heusschen, R., De Raeve, H., Schots, R., Vanderkerken, K., Caers, J., & Menu, E. (2018). Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer Journal, 8 (11), 105. doi:10.1038/s41408-018-0139-7
Peer Reviewed verified by ORBi

Contact ORBi